VR Logo

Lyka Labs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1976

Chairman: N N Gandhi

Managing Director: Kunal N Gandhi

Group: --

Listing: NSE: LYKALABS, BSE: 500259

Headquarters: Ankleshwar, Gujarat

Website: www.lykalabs.com

Key Facts

Market cap: R 46.76 Cr

Revenue (TTM): R 39.84 Cr

Earnings (TTM): R -36.38 Cr

Cash: R 1.58 Cr

Total Debt: R 96.42 Cr

Promoters' ownership: 19.88%

Liquidity: Moderate

52 Week range: R 9.60 - 26.15

Face value: R10.00

Shares outstanding: 2,86,90,000

10 Years Aggregate:

  • CFO: 240.24 Cr
  • EBITDA: 146.47 Cr
  • Net Profit: -46.29 Cr

Stock Performance

Time Period Lyka Labs S&P BSE Healthcare S&P BSE Small Cap
YTD-17.8617.93-15.54
1 month-6.123.294.22
3 months-6.6713.75-15.99
1 Year-37.3517.97-22.54
3 Years-30.974.50-8.90
5 Years-23.99-0.111.33
10 Years-5.4311.122.98
As on 03-Jun-2020
Year Lyka Labs S&P BSE Small Cap S&P BSE Healthcare
2019-35.10-6.85-3.55
2018-52.68-23.41-5.89
201720.8359.640.49
2016-59.021.77-12.88
2015373.256.7615.06
2014121.8969.2447.43
2013-2.59-11.2322.55